arjunolic acid has been researched along with Liver Dysfunction in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Das, J; Ghosh, J; Manna, P; Sil, PC | 1 |
1 other study(ies) available for arjunolic acid and Liver Dysfunction
Article | Year |
---|---|
Contribution of type 1 diabetes to rat liver dysfunction and cellular damage via activation of NOS, PARP, IkappaBalpha/NF-kappaB, MAPKs, and mitochondria-dependent pathways: Prophylactic role of arjunolic acid.
Topics: Animals; Apoptosis; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; DNA Fragmentation; Free Radical Scavengers; Glutathione; I-kappa B Proteins; Lipid Peroxidation; Liver; Liver Diseases; Male; Mitochondria; Mitogen-Activated Protein Kinases; NF-kappa B; NF-KappaB Inhibitor alpha; Nitric Oxide Synthase Type II; Oxidative Stress; Poly(ADP-ribose) Polymerases; Protein Carbonylation; Rats; Reactive Oxygen Species; Triterpenes | 2010 |